Comparison of olanzapine and risperidone use in psychiatric rehabilitation

András Klebovich, Zoltán Bujdosó, Andrea Meskó, R. Zelkó

Research output: Contribution to journalArticle

Abstract

Background: Because olanzapine and risperidone have similar efficacy and tolerability in the treatment of schizophrenia and these two agents are the most widely used atypical antipsychotics in Hungary, the utilisation of the drugs is a relevant consideration. The purpose of this study was to follow the utilisation trend of olanzapine and risperidone in the Gálfi Béla Hospital, which is a specialised institute on psychiatric rehabilitation. Methods: Data regarding dosages and psychiatrists' clinical preferences were collected through studying hospital charts in the Gálfi Béla Hospital during the period 1999-2003. Results: Utilisation of the agents indicated that there was an increase of use for the whole examined period in the Gálfi Béla Hospital, although unambiguous growth began only in 2001. Conclusions: Hospital chart analysis shows that both drugs were used to a large extent and risperidone use is increasing more rapidly, which is justified by the gerontopsychiatric profile of the hospital.

Original languageEnglish
Pages (from-to)573-576
Number of pages4
JournalTherapie
Volume60
Issue number6
DOIs
Publication statusPublished - 2005

Fingerprint

olanzapine
Risperidone
Drug Utilization
Hungary
Antipsychotic Agents
Psychiatry
Psychiatric Rehabilitation
Schizophrenia

Keywords

  • Hungary
  • Olanzapine
  • Psychiatric rehabilitation
  • Risperidone

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Comparison of olanzapine and risperidone use in psychiatric rehabilitation. / Klebovich, András; Bujdosó, Zoltán; Meskó, Andrea; Zelkó, R.

In: Therapie, Vol. 60, No. 6, 2005, p. 573-576.

Research output: Contribution to journalArticle

Klebovich, András ; Bujdosó, Zoltán ; Meskó, Andrea ; Zelkó, R. / Comparison of olanzapine and risperidone use in psychiatric rehabilitation. In: Therapie. 2005 ; Vol. 60, No. 6. pp. 573-576.
@article{06eeb8ddc51344c4bda893420fa56e37,
title = "Comparison of olanzapine and risperidone use in psychiatric rehabilitation",
abstract = "Background: Because olanzapine and risperidone have similar efficacy and tolerability in the treatment of schizophrenia and these two agents are the most widely used atypical antipsychotics in Hungary, the utilisation of the drugs is a relevant consideration. The purpose of this study was to follow the utilisation trend of olanzapine and risperidone in the G{\'a}lfi B{\'e}la Hospital, which is a specialised institute on psychiatric rehabilitation. Methods: Data regarding dosages and psychiatrists' clinical preferences were collected through studying hospital charts in the G{\'a}lfi B{\'e}la Hospital during the period 1999-2003. Results: Utilisation of the agents indicated that there was an increase of use for the whole examined period in the G{\'a}lfi B{\'e}la Hospital, although unambiguous growth began only in 2001. Conclusions: Hospital chart analysis shows that both drugs were used to a large extent and risperidone use is increasing more rapidly, which is justified by the gerontopsychiatric profile of the hospital.",
keywords = "Hungary, Olanzapine, Psychiatric rehabilitation, Risperidone",
author = "Andr{\'a}s Klebovich and Zolt{\'a}n Bujdos{\'o} and Andrea Mesk{\'o} and R. Zelk{\'o}",
year = "2005",
doi = "10.2515/therapie:2005080",
language = "English",
volume = "60",
pages = "573--576",
journal = "Therapie",
issn = "0040-5957",
publisher = "EDP Sciences",
number = "6",

}

TY - JOUR

T1 - Comparison of olanzapine and risperidone use in psychiatric rehabilitation

AU - Klebovich, András

AU - Bujdosó, Zoltán

AU - Meskó, Andrea

AU - Zelkó, R.

PY - 2005

Y1 - 2005

N2 - Background: Because olanzapine and risperidone have similar efficacy and tolerability in the treatment of schizophrenia and these two agents are the most widely used atypical antipsychotics in Hungary, the utilisation of the drugs is a relevant consideration. The purpose of this study was to follow the utilisation trend of olanzapine and risperidone in the Gálfi Béla Hospital, which is a specialised institute on psychiatric rehabilitation. Methods: Data regarding dosages and psychiatrists' clinical preferences were collected through studying hospital charts in the Gálfi Béla Hospital during the period 1999-2003. Results: Utilisation of the agents indicated that there was an increase of use for the whole examined period in the Gálfi Béla Hospital, although unambiguous growth began only in 2001. Conclusions: Hospital chart analysis shows that both drugs were used to a large extent and risperidone use is increasing more rapidly, which is justified by the gerontopsychiatric profile of the hospital.

AB - Background: Because olanzapine and risperidone have similar efficacy and tolerability in the treatment of schizophrenia and these two agents are the most widely used atypical antipsychotics in Hungary, the utilisation of the drugs is a relevant consideration. The purpose of this study was to follow the utilisation trend of olanzapine and risperidone in the Gálfi Béla Hospital, which is a specialised institute on psychiatric rehabilitation. Methods: Data regarding dosages and psychiatrists' clinical preferences were collected through studying hospital charts in the Gálfi Béla Hospital during the period 1999-2003. Results: Utilisation of the agents indicated that there was an increase of use for the whole examined period in the Gálfi Béla Hospital, although unambiguous growth began only in 2001. Conclusions: Hospital chart analysis shows that both drugs were used to a large extent and risperidone use is increasing more rapidly, which is justified by the gerontopsychiatric profile of the hospital.

KW - Hungary

KW - Olanzapine

KW - Psychiatric rehabilitation

KW - Risperidone

UR - http://www.scopus.com/inward/record.url?scp=33645788834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645788834&partnerID=8YFLogxK

U2 - 10.2515/therapie:2005080

DO - 10.2515/therapie:2005080

M3 - Article

VL - 60

SP - 573

EP - 576

JO - Therapie

JF - Therapie

SN - 0040-5957

IS - 6

ER -